Revolutionary blood test to fight malariaApril 29th, 2009 - 2:34 pm ICT by ANI
Washington, April 29 (ANI): A simple blood test can offer valuable support to healthcare in the fight against malaria, scientists at Karolinska Institute have found.
According to their study, the rapid diagnostic test (RDT) for malaria infection could help ensure that a greater number of patients receive the right treatment at no extra cost for the healthcare services.
“Since the existing test methods are too complicated and expensive for most primary health care clinics in Africa people are prescribed malaria treatment based on presence of fever only”, says Dr Anders Bjorkman, who led the study at Karolinska Institutet s research centre in Zanzibar, Tanzania.
“With an improved diagnostic tool, treatment can be targeted to patients with confirmed malaria infection,” Bjorkman added.
Malaria RDT is a relatively new diagnostic method, which measures the presence of a protein produced by the malaria parasite Plasmodium falciparum in a sample of blood taken from the finger. The test requires no advanced laboratory equipment or training, and is already in clinical use.
The study is the first broad-front evaluation of the test in clinical operation. It involved four clinics on Zanzibar and data from 1,887 adults and children who all had fever within 48 hours prior to enrolment in the study.
The subjects were divided into two groups, one that was given a regular medical examination and diagnosed on the basis of symptoms only, and one that was also tested with RDT.
All patients who were diagnosed with malaria, regardless of method, were prescribed artemisinin-based combination therapy (ACT), a treatment based on a Chinese plant called Artemisia annua.
When the patients were followed up two weeks after treatment, it was observed that significantly fewer patients who had been tested with RDT received ACT treatment: 36 per cent, as opposed to 85 per cent of the control (non-RDT) group.
However, more antibiotics were prescribed for the RDT group. The number of patient revisits made on account of the perceived ineffectiveness of ACT was also lower in the RDT group.
“This might well prove a minor revolution in the treatment of malaria in the poor countries that are most severely affected. It also means that we’ll get a better picture of the spread of the disease, which will make it possible to develop new, improved control strategies,” said Bjorkman.
The study is published in the journal PLoS Medicine. (ANI)
- Natural compounds could pave way for novel anti-malaria drugs - Mar 15, 2011
- Resistance to malaria drug rings alarm bells - Apr 08, 2012
- High dose of oxygen boosts natural cancer treatment - Apr 05, 2011
- Largest clinical trial confirms new drug for worldwide malaria treatment - Nov 07, 2010
- Malaria parasite developing drug resistance in Cambodia - Jul 30, 2009
- Boosting availability of potent anti-malaria drug - Jan 18, 2012
- World Health Organization issues guidelines for malaria treatment - Mar 10, 2010
- Now, a cheap and organic drug treatment for malaria - Aug 17, 2010
- Community-based treatment of malaria, pneumonia could save lives: Study - Sep 22, 2010
- New study could improve diagnosis and treatment of malaria - Sep 09, 2010
- Chinese scientist wins US award for malaria drug - Sep 15, 2011
- New test promptly tells bacterial, viral infections apart - Jun 30, 2011
- False diagnosis of TB in HIV patients is fatal - May 17, 2010
- Blood-clotting agent can be used to diagnose fatal genetic diseases - Feb 04, 2011
- Antibiotics ineffective against viral sinus infections - Mar 22, 2012
Tags: annua, bjorkman, combination therapy, diagnostic method, diagnostic tool, falciparum, health care clinics, healthcare services, karolinska institute, karolinska institutet, laboratory equipment, malaria infection, malaria parasite plasmodium, malaria treatment, medical examination, primary health care, rapid diagnostic test, rdt group, test methods, zanzibar tanzania